Atherectomy Device Market Set to Hit US$ 3.71 Billion by 2034

The global market for atherectomy devices (アテレクトミーデバイス市場) is poised for significant growth, with a valuation of US$ 1.23 billion in 2024 expected to soar to US$ 3.71 billion by 2034. Projections indicate a robust 11.6% compound annual growth rate (CAGR) over the next decade.

Atherectomy, a minimally invasive procedure aimed at clearing atherosclerosis in arteries using rotating devices or narrow tubes with blades, is garnering attention as an alternative to angioplasty. However, its superiority over angioplasty remains unproven at present.

Key trends driving the atherectomy device market include global concerns regarding poor dietary habits, sedentary lifestyles, and the rising incidence of peripheral artery diseases and coronary artery diseases. Additionally, the increasing prevalence of obesity and diabetes is anticipated to further fuel demand for atherectomy devices worldwide in the years ahead.

𝗚𝗲𝘁 𝗙𝗿𝗲𝗲 𝗦𝗮𝗺𝗽𝗹𝗲 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗥𝗲𝗽𝗼𝗿𝘁 𝗖𝗼𝗽𝘆:

https://www.factmr.com/connectus/sample?flag=S&rep_id=9164

𝗠𝗮𝗿𝗸𝗲𝘁 𝗞𝗲𝘆 𝗗𝗿𝗶𝘃𝗲𝘀:

Increasing Prevalence of Peripheral Artery Disease (PAD): The rising incidence of PAD, driven by factors such as aging populations and lifestyle changes, is a significant driver for the atherectomy device market. As PAD cases continue to surge globally, the demand for effective treatment options, including atherectomy devices, is expected to increase.

Technological Advancements: Ongoing advancements in atherectomy device technology, including the development of minimally invasive and precision-guided devices, are enhancing their efficacy and safety profiles. Innovations such as laser atherectomy, rotational atherectomy, and orbital atherectomy are expanding treatment options, attracting both patients and healthcare providers.

Growing Preference for Minimally Invasive Procedures: Patients are increasingly opting for minimally invasive procedures due to their shorter recovery times, reduced hospital stays, and lower risks of complications compared to traditional surgeries. Atherectomy devices, offering precise lesion targeting and minimal tissue damage, align well with this trend, driving market growth.

Expanding Aging Population: With the global population aging, the prevalence of vascular diseases, including PAD, is expected to rise. Elderly individuals are more susceptible to atherosclerosis and related complications, creating a growing patient pool for atherectomy procedures and devices.

Increasing Awareness and Diagnostic Capabilities: Rising awareness about vascular diseases among both patients and healthcare providers, coupled with advancements in diagnostic techniques, is leading to earlier detection and treatment of PAD. This proactive approach is fueling the demand for atherectomy devices as part of comprehensive treatment strategies.

𝗙𝘂𝘁𝘂𝗿𝗲 𝗢𝘂𝘁𝗹𝗼𝗼𝗸:

The future outlook for the atherectomy device market (Marché des dispositifs d'athérectomie) appears promising, driven by a combination of technological innovation, demographic trends, and evolving treatment paradigms. Minimally invasive procedures will likely continue to gain traction, supported by ongoing advancements in device design and capabilities. Additionally, as healthcare systems strive to improve patient outcomes and reduce healthcare costs, the demand for effective, less invasive treatment options like atherectomy devices is expected to grow. Market players investing in research and development to enhance device performance, expand indications, and address unmet clinical needs are poised to capitalize on these opportunities and drive further market expansion in the coming years. However, regulatory considerations, reimbursement challenges, and competition from alternative treatment modalities will remain key factors influencing market dynamics and growth trajectories. Overall, the atherectomy device market is positioned for steady growth, fueled by the increasing burden of vascular diseases and the continued quest for safer, more effective treatment options.

𝗠𝗮𝗿𝗸𝗲𝘁 𝗞𝗲𝘆 𝗣𝗹𝗮𝘆𝗲𝗿𝘀:

Avinger Inc.
Medtronic plc.
Abbott Laboratories
Boston Scientific Corporation
Cardinal Health Inc.
Biotronik
Minnetronix Inc.
𝗖𝗼𝗺𝗽𝗲𝘁𝗶𝘁𝗶𝘃𝗲 𝗟𝗮𝗻𝗱𝘀𝗰𝗮𝗽𝗲:

Key players in the atherectomy system industry are prioritizing regulatory approval to expedite the commercialization of their products.

In October 2023, Cardio Flow, a US-based medical device company, disclosed its attainment of a 510(k) clearance from the FDA for its orbital atherectomy peripheral platform, named FreedomFlow. Employing a catheter-based design coupled with modern mechanisms, FreedomFlow effectively targets plaque blockages within arteries.

Similarly, in January 2021, Cardiovascular Systems Inc. (CSI), a prominent entity dedicated to advancing innovative solutions for cardiovascular ailments, revealed the acquisition of a CE mark for its groundbreaking Diamondback 360® Coronary Orbital Atherectomy System. This milestone facilitated CSI's entry into the European market, fostering significant expansion opportunities for the company.Top of Form



𝗥𝗲𝗮𝗱 𝗠𝗼𝗿𝗲: https://www.factmr.com/report/atherectomy-device-market

𝗠𝗮𝗿𝗸𝗲𝘁 𝗞𝗲𝘆 𝗦𝗲𝗴𝗺𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻:

By Device Type :
Rotational Atherectomy Devices
Directional Atherectomy Devices
Orbital Atherectomy Devices
Laser Atherectomy Devices
By Indication :
Coronary Artery Diseases
Peripheral Artery Diseases
By End User :
Hospitals
Ambulatory Surgical Centers
Office-Based Labs (OBL)
By Region :
North America
Latin America
Europe
East Asia
South Asia & Oceania
Middle East & Africa
𝗘𝘅𝗽𝗹𝗼𝗿𝗲 𝗠𝗼𝗿𝗲 𝗥𝗲𝗹𝗮𝘁𝗲𝗱 𝗦𝘁𝘂𝗱𝗶𝗲𝘀 𝗣𝘂𝗯𝗹𝗶𝘀𝗵𝗲𝗱 𝗯𝘆 𝗙𝗮𝗰𝘁.𝗠𝗥 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵:

Hemorrhoids Treatment Device Market (痔治療機器市場):

https://www.factmr.com/report/577/hemorrhoids-treatment-device-market

Next Generation Wound Closure Device Market (次世代創傷閉鎖デバイス市場):

https://www.factmr.com/report/582/next-generation-wound-closure-device-market

Portable Device Charging Kiosks Market (ポータブル デバイス充電キオスク市場 ):

https://www.factmr.com/report/793/portable-device-charging-kiosks-market

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

𝐀𝐛𝐨𝐮𝐭 𝐅𝐚𝐜𝐭.𝐌𝐑
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.